Relmada Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. 

CEO
Sergio Traversa
CEOSergio Traversa
Employees
10
Employees10
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2012
Founded2012
Employees
10
Employees10

RLMD Key Statistics

Market cap
124.16M
Market cap124.16M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
261.00K
Average volume261.00K
High today
$4.44
High today$4.44
Low today
$4.07
Low today$4.07
Open price
$4.22
Open price$4.22
Volume
246.86K
Volume246.86K
52 Week high
$38.68
52 Week high$38.68
52 Week low
$1.81
52 Week low$1.81

Analyst ratings

67%

of 6 ratings
Buy
33.3%
Hold
66.7%
Sell
0%

RLMD Earnings

-$2.44
-$1.63
-$0.81
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 22, After Hours
ActualExpected Mar 22, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.